C4A and Parkinson disease: Interestingly, levels of the key complement components of the alternative and classical pathways, C3 and C4, were previously reported to be lower in non-motor PD compared with healthy controls [47], while severity of disease has been related to C3 and factor H levels in PD and AD patients [48].